BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2020
View Archived Issues
Enrollment ongoing in first-in-human study of JNJ-74856665 in AML or MDS
Read More
Phase II study of KN-046 in patients with thymic carcinoma begins
Read More
Aravive opens enrollment in phase Ib/II study of AVB-S6-500 in clear cell renal cell carcinoma
Read More
Missense variants in c-Myc, CDK4 and ARHGDIA genes identified as potential causes of MODY by WES
Read More
CureVac initiates pivotal phase IIb/III study of CVnCoV
Read More
TCR2 presents positive interim data from ongoing phase I/II study of gavo-cel
Read More
ADU-S100 plus pembrolizumab appears well tolerated in recurrent/metastatic HNSCC
Read More
AB-729 results in robust reduction in HBsAg in patients with chronic hepatitis B
Read More
Nuclear receptors protect against kidney disease
Read More
First patient dosed in phase II BLUEPRINT study of BLU-5937
Read More
Arvinas reports interim clinical data for ARV-471 and ARV-110
Read More
FDA clears IND for phase I study of LB-1901 in relapsed or refractory T-cell lymphoma
Read More
Voronoi patents FLT3 and/or MAP4K1 and/or CDK6/cyclin D1 inhibitors
Read More
U.S. researchers synthesize new KRAS mutant inhibitors
Read More
Gilead Sciences identifies MAP4K1 inhibitors
Read More
Poxel presents further phase IIa data for PXL-770 in NASH
Read More
Bolting TLR agonist to antibody converts cold tumors
Read More
InvisiMask human antibody nasal spray protects against SARS-CoV-2 infection in vivo
Read More
BioTheryX presents new GSPT1 inhibitors
Read More
Phase III KESTREL study of Beovu in DME meets primary endpoint
Read More
Suzhou Ribo Life Science describes new PCSK9-targeting siRNA
Read More
Phase II trial examines DS-1062 for advanced or metastatic NSCLC with actionable genomic alterations
Read More
European Commission approves Trixeo Aerosphere for maintenance treatment of COPD
Read More
Mesoblast reports topline phase III data on Revascor in advanced chronic heart failure
Read More
SOD1G93A Grm5+/- mouse model highlights mGlu5 receptors as a target in amyotrophic lateral sclerosis
Read More
FDA approves Klisyri for actinic keratosis on the face or scalp
Read More
TOT Biopharm presents promising phase I data for trastuzumab ADC TAA-013
Read More